|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 243.10 EUR | -0.04% |
|
+2.65% | +3.66% |
| 14/07 | Where would AI lead Pharma in the long run? |  |
| 13/07 | Antengene Receives $60 Million Milestone in UCB Licensing Deal | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
- Charts UCB
Select your edition
All financial news and data tailored to specific country editions
